Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system.
about
Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins.Obesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination.Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humansAssessment of influenza virus hemagglutinin stalk-based immunity in ferrets.Divergent H7 immunogens offer protection from H7N9 virus challenge.Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in MiceImmune history profoundly affects broadly protective B cell responses to influenza.Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin.An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans.Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin.A single immunization with modified vaccinia virus Ankara-based influenza virus H7 vaccine affords protection in the influenza A(H7N9) pneumonia ferret model.Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses.Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses.New England harbor seal H3N8 influenza virus retains avian-like receptor specificity.Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of ProtectionAge Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans.Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer ProtectionNovel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model.Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans.Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model.Cross-Reactive and Cross-Neutralizing Activity of Human Mumps Antibodies Against a Novel Mumps Virus From Bats.Generation of a serum free CHO DG44 cell line stably producing a broadly protective anti-influenza virus monoclonal antibody.Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.Microcrystallography of Protein Crystals and In Cellulo Diffraction.Progesterone-Based Contraceptives Reduce Adaptive Immune Responses and Protection against Sequential Influenza A Virus Infections.An H10N8 influenza virus vaccine strain and mouse challenge model based on the human isolate A/Jiangxi-Donghu/346/13.Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge ModelDevelopment of an influenza virus protein microarray to measure the humoral response to influenza virus infection in mallards.Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection.A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies.A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice.Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans.Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations.NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses.
P2860
Q30151352-45D9095B-4094-43B6-8080-766E8D6CE279Q30151873-95EE1CFD-15E8-4D61-BFC0-03B218F795EBQ30207889-AE359C1B-8927-48F7-9351-0CB55258DDA7Q30357665-3792B664-A4C0-42FF-B472-E08FE91B1807Q30358196-6B5A31BD-C990-40CE-839F-43A620395B93Q30371836-86CAE74C-EC68-47B5-B7CA-00831B873CECQ30380785-8B809BBF-3AA0-4DE5-AB12-63CFDDBEC99CQ30382131-09F0A73C-A6FE-4784-A628-A13A2A0ADB60Q30382576-3EE05C9C-DE3B-4D35-B004-940A2FB9C57FQ30400179-1158158D-4BEF-41C2-941C-A5C2462FCFA1Q34057737-3B26A3F6-B278-43AC-B4CA-C8F0FB4A005EQ34594065-7C1B811D-9CCF-4F4F-8CC7-FE6E0EB8ED42Q35474243-172AF0E9-63E0-4DDF-BF0E-237BB6F0873DQ35618503-7145C0E9-8073-45D8-BC1B-46AF972BC7CFQ35677624-B3691693-2F63-4980-A987-2591181D6DC5Q35756765-0761657B-9FF5-41CF-A560-F95B1AF64B15Q35926768-08ED2023-C7A4-4B43-A9B9-3B832CA1CCF0Q35990859-98BBFB8A-72E4-4C8C-855D-85F97C61E163Q36496580-1827F356-A102-4622-8743-AD5190880B35Q36991414-4796FB96-FA7A-4219-9AED-5D587D2A3F93Q38673543-E25B75EE-3C32-48AA-BC3C-AF523BA9C716Q38734580-C4F64DC6-296F-4853-BD6A-1A91412678EBQ38868293-CDF091FC-8C7F-4CE0-8BB5-FF9388769B7AQ39218193-58686501-D8BE-4B61-8A8F-76385C2B429BQ40041335-CF82EF5B-24D5-4194-AF18-1C1BA9ACA561Q40075978-027826E9-022E-4DF5-A9B2-300FA00652F1Q40103005-11192211-A2B0-4782-B51F-51EC68E37354Q40339519-76F1041D-E596-47E0-8773-D9CF03E44B55Q41531938-82C0C8E5-A3D2-40BE-A90D-CDE62B0D902CQ41676246-42F48972-534D-4A26-9F1D-F50DF7DA6FF0Q45323759-5F00DFE4-E9D2-4E2E-8E6E-27B652149F28Q46060826-8EC85276-FF35-4E56-AF84-C23CC2DA62CFQ47108278-EDBF5201-3258-4AC6-A6A8-5AF2E74BA645Q47132783-26C0857C-13A7-42D6-9D9D-699B159F55A1Q47137425-395E5CDE-E13B-4E1D-B1A3-51E73440F4DAQ52602393-B6D2720C-C796-48CF-9A48-9057D48C795FQ52607528-4F8E0B10-9FC7-4855-BDDC-0D569EF602BCQ52609074-7ED0CF0C-9A67-42DD-B983-B7DD1FE331FAQ55260817-F97EB19D-D9CD-4E5F-80EB-748DDD378C3CQ55306089-F24802A1-3593-4B52-BA72-2469D39294EF
P2860
Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Expression of functional recom ...... baculovirus expression system.
@en
Expression of functional recom ...... baculovirus expression system.
@nl
type
label
Expression of functional recom ...... baculovirus expression system.
@en
Expression of functional recom ...... baculovirus expression system.
@nl
prefLabel
Expression of functional recom ...... baculovirus expression system.
@en
Expression of functional recom ...... baculovirus expression system.
@nl
P2860
P356
P1476
Expression of functional recom ...... baculovirus expression system.
@en
P2093
Irina Margine
P2860
P304
P356
10.3791/51112
P577
2013-11-06T00:00:00Z